Results 221 to 230 of about 10,941,841 (309)

Erratum to "Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1283-1287]. [PDF]

Kidney Int Rep
Barbour SJ, Coppo R, Barratt J, Er L, Lafayette R, Heerspink HJL, Rizk DV, Liew A, Jha V, Zhang H, Suzuki Y, Trimarchi H, Cattran DC, International IgA Nephropathy Network Research Group.   +13 more
europepmc   +1 more source

Sciential Issue 4

Sciential - McMaster Undergraduate Science Journal, 2020
openaire   +2 more sources

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Erratum to "Discordant Results Between Creatinine- and Cystatin C-based Equations for Estimating GFR" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1248-1259]. [PDF]

Kidney Int Rep
Delanaye P, Flamant M, Vidal-Petiot E, Björk J, Nyman U, Grubb A, Bakker SJL, de Borst MH, van Londen M, Derain-Dubourg L, Rule AD, Eriksen BO, Melsom T, Sundin PO, Ebert N, Schaeffner E, Hansson M, Littmann K, Larsson A, Stehlé T, Cavalier E, Bukabau JB, Sumaili EK, Yayo E, Mariat C, Moranne O, Christensson A, Lanot A, Pottel H.   +28 more
europepmc   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Corrigendum to "Effect of chamomile aromatherapy with and without oxygen on pain of women in post cesarean section with spinal anaesthesia: A randomized clinical trial" [Heliyon Volume 9, Issue 4, April 2023, Article e15323]. [PDF]

Heliyon
Habibabad HZ, Afrasiabifar A, Mansourian A, Mansourian M, Hosseini N.   +4 more
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

v. 69, issue 1, September 4, 2001 [PDF]

, 2001

core   +1 more source